Alerts will be sent to your verified email
Verify EmailCELLPOINT
|
Cell Point (India)
|
Johnson Pharmacare
|
Sarthak Inds
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.42 % | 0.03 % | 4.03 % |
|
5yr average Equity Multiplier
|
4.01 | 1.04 | 1.74 |
|
5yr Average Asset Turnover Ratio
|
2.93 | 0.02 | 1.64 |
|
5yr Avg Net Profit Margin
|
0.88 % | -9.6 % | 1.5 % |
|
Price to Book
|
0.38 | 0.48 | 0.61 |
|
P/E
|
12.39 | 0.0 | 10.47 |
|
5yr Avg Cash Conversion Cycle
|
51.94 Days | 0.0 | 18.6 Days |
|
Inventory Days
|
51.27 Days | 0.0 | 27.25 Days |
|
Days Receivable
|
0.89 Days | 0.0 | 13.95 Days |
|
Days Payable
|
17.65 Days | 45.31 Days | 84.98 Days |
|
5yr Average Interest Coverage Ratio
|
1.54 | -674.72 | 2.62 |
|
5yr Avg ROCE
|
24.23 % | -0.68 % | 7.9 % |
|
5yr Avg Operating Profit Margin
|
3.71 % | -9.65 % | -0.2 % |
|
5 yr average Debt to Equity
|
2.25 | 0.02 | 0.07 |
|
5yr CAGR Net Profit
|
26.78 % | n/a | 25.47 % |
|
5yr Average Return on Assets
|
2.63 % | -0.67 % | 2.27 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.06 % | 0.0 | 36.21 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Cell Point (India)
|
Johnson Pharmacare
|
Sarthak Inds
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|